B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity
Annals of Clinical and Translational Neurology · 2024
DOI: 10.1002/acn3.52171 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Jeffrey L Bennett und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado School of Medicine, Anschutz Medical Camp…. Hauptthemen laut MEDLINE: Aquaporin 4, Autoantibodies, B-Lymphocytes, Neuromyelitis Optica. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
This post hoc analysis of the randomized, placebo‐controlled N‐MOmentum study (NCT02200770) of inebilizumab in neuromyelitis optica spectrum disorder (NMOSD) evaluated relationships between circulating B‐cell subsets and aquaporin‐4 immunoglobulin G (AQP4‐lgG) titers and attacks. Among participants receiving placebo, CD20 + and CD27 + B‐cell counts were modestly increased from the pre‐attack visit to attack; plasmablast/plasma cell gene signature was increased from baseline to the pre‐attack visit ( p = 0.016) and from baseline to attack ( p = 0.009). With inebilizumab treatment, B‐cell subset counts decreased and did not increase with attacks. No difference in change of AQP4‐IgG titers from baseline to time of attack was observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
- Neurology, Laboratory Medicine and Pathology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin, Berlin, Germany.
- Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.
- Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
- Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
ORCID-Profile: Jeffrey L Bennett, Sean J Pittock, Friedemann Paul, Ho Jin Kim, Sarosh R Irani, Bruce A C Cree
Förderung
- Medical Research Council
Zitieren
APA
Bennett, J. L., Pittock, S. J., Paul, F., Kim, H. J., Irani, S. R., O'Connor, K. C., Patterson, K. R., Smith, M. A., Gunsior, M., Mittereder, N., Rees, W. A., Cimbora, D., & Cree, B. A. C. (2024). B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52171
Vancouver
Bennett JL, Pittock SJ, Paul F, Kim HJ, Irani SR, O'Connor KC, et al. B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52171
BibTeX
@article{Bennett2024,
author = {Bennett, Jeffrey L and Pittock, Sean J and Paul, Friedemann and Kim, Ho Jin and Irani, Sarosh R and O'Connor, Kevin C and Patterson, Kristina R and Smith, Michael A and Gunsior, Michele and Mittereder, Nanette and Rees, William A and Cimbora, Daniel and Cree, Bruce A C},
title = {B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
doi = {10.1002/acn3.52171}
}
EUVIMED